Chronic Myelogenous Leukemia - Chronic Phase
9 clinical trials · Condition
◉ Watch Chronic Myelogenous Leukemia - Chronic Phase
| Record | Firm | Date |
|---|---|---|
| Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation (NCT04666259) | Novartis Pharmaceuticals | 2021-05-25 |
| Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation (NCT03842696) | University of Michigan Rogel Cancer Center | 2020-02-04 |
| A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) (NCT04925141) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2016-05-10 |
Track Chronic Myelogenous Leukemia - Chronic Phase automatically
Every clearance here is in the API, with alerts when new ones post.